Ranitidine Urgent Product Recall
3 February 2020
A product recall is a request from a manufacturer to return a product after the discovery of safety issues or product defects that might endanger the consumer.
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring that the medicines and medical devices work and are acceptably safe, the MHRA has issued the attached alert.
Medreich Plc is recalling all unexpired stock of the above products from pharmacies and wholesalers as a precautionary measure due to possible contamination with an impurity N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential.
This recall has been requested by the manufacturer, see attached for more information.
This is a Class 2 Alert.
| NVS Product Code | Product Description | PL Number | Batch Numbers |
| 146274 | Ranitidine 150mg Tablets | 21880/0091 | 370779 770064 770083 770084 870126 870159 870163 870164 970219 |
| 60343 | Ranitidine 300mg Tablets | 21880/0092 | 370733 770090 770092 870181 |
Action is required from you whether you do or do not have this product in stock, please see the attached document for more information on what to do next.
If you require any further information please contact our Customer Service Department on 01782 771 111.
Kind regards
Andrew Duxbury
(Responsible Person)